Biggest News Aggregation in the World
📰 Steve Kanner News

Steve Kanner News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Steve Kanner. Real-time updates on events, politics, business and more.

Caribou Biosciences Announces FDA Clearance of IND Application for CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

18.10.2023 - - AMpLify Phase 1 clinical trial to initiate patient enrollment by mid-2024 - - CB-012 is the first allogeneic CAR-T cell therapy with both checkpoint disruption and immune cloaking to enter the clinic - BERKELEY, Calif., Oct. 18, 2023 (GLOBE ... Seite 1
United States Rachel Haurwitz Steve Kanner Department Of Leukemia University Of Texas Md Anderson Cancer Center Lify Phase

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Caribou Biosciences Selects ROR1 as the Target for CB-020, an iPSC-derived Allogeneic CAR-NK Cell Therapy

12.12.2022 - - Data supporting selection of ROR1 for CB-020 and armoring strategies for Caribou’s CAR-NK cell platform to be presented at AACR-JCA Conference today - - Caribou is using its chRDNA next-gen CRISPR technology to engineer and advance both CAR-NK ... Seite 1
United States Steve Kanner American Association For Cancer Research Caribou Biosciences Inc Japanese Cancer Association American Association

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science